This announcement is a separate document:
湖南启元律师事务所关于圣湘生物科技股份有限公司2023年限制性股票激励计划授予价格调整及第一个归属期归属条件成就的法律意见书
Legal Opinion of Qi Yuan Law Firm, regarding the adjustment of the grant price of restricted stock options and the achievement of the first vesting condition of Sansure Biotech Inc.'s 2023 Restricted Stock Incentive Plan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.